A review of vitamin D supplementation as disease-modifying therapy

Area of Science:

• Neuroimmunology
• Endocrinology
• Epidemiology

Background:

• Multiple sclerosis (MS) is an inflammatory central nervous system (CNS) demyelinating disease, a leading cause of disability in young adults.
• MS prevalence is notably higher in regions with lower sunlight exposure and vitamin D levels.
• Vitamin D, a crucial fat-soluble compound, plays a significant role in immune system regulation.

Purpose of the Study:

• To evaluate the association between serum vitamin D levels and MS risk and disease severity.
• To explore the potential of vitamin D supplementation as an adjunctive therapy for MS.
• To review current evidence and provide recommendations for off-label vitamin D use in MS management.

Main Methods:

• Review of existing literature on vitamin D levels in MS patients.
• Analysis of studies investigating vitamin D's role in MS pathogenesis and progression.
• Evaluation of preliminary clinical trial data on vitamin D add-on therapy for MS.

Main Results:

• Lower serum vitamin D levels correlate with an increased risk of developing MS.
• Reduced vitamin D is associated with a more severe disease course in individuals with MS.
• Preliminary studies suggest potential benefits of vitamin D supplementation, but lack significant evidence of clinical efficacy.

Conclusions:

• Vitamin D's role in MS pathogenesis warrants further investigation.
• Current evidence does not support vitamin D as a standalone or definitively effective add-on therapy for MS.
• Recommendations for off-label vitamin D supplementation require careful consideration of existing data and patient-specific factors.